Trials / Recruiting
RecruitingNCT06006026
The Safety of Ropivacaine TAP Block Combined With Intravenous Lidocaine in Patients Undergoing Colorectal Cancer Surgery
The Safety of Ropivacaine Transversus Abdominis Plane Block Combined With Intravenous Lidocaine in Patients Undergoing Colorectal Cancer Surgery: a Single Center, Open Label Dose Escalation Study
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 9 (estimated)
- Sponsor
- West China Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Many studies have confirmed the analgesic effect of intravenous infusion of lidocaine in abdominal surgery. Transversus abdominis plane (TAP) block is also often recommended for abdominal surgery. Ropivacaine TAP block and intravenous lidocaine infusion are important components of multimodal analgesia for colorectal surgery. However, both of them are the local anesthetics and the safety of combination is unknown, so investigators design the study to explore the safety of the synergistic application of ropivacaine TAP block and intravenous lidocaine infusion in patients undergoing colorectal surgery.
Detailed description
Transversus abdominis plane (TAP) block is often recommended for abdominal surgery. Ropivacaine TAP block and intravenous lidocaine infusion are important components of multimodal analgesia for colorectal surgery. However, both of them are the local anesthetics and the safety of combination is unknown, so investigators design the study to explore the safety of the synergistic application of ropivacaine TAP block and intravenous lidocaine infusion in patients undergoing colorectal surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ropivacaine Hydrochloride 10 MG/ML [Naropin] | According to the specified dosage, dilute 1% ropivacaine to 0.2% and inject 1/2 of the total amount on each side. |
Timeline
- Start date
- 2023-08-28
- Primary completion
- 2024-05-10
- Completion
- 2024-05-20
- First posted
- 2023-08-23
- Last updated
- 2024-04-18
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06006026. Inclusion in this directory is not an endorsement.